Business SK bioscience submits IND to the Ministry of Food and Drug Safety
By Diplomacy Journal Lee Kap-soo SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced on Sept. 2 that it has submitted an IND (Investigational New Drug application) to the Ministry of Food and Drug Safety for a global Phase 3 clinical trial of SKYVaricella to add the 2-dose (two-shot) indication, aligning with evolving international standards that increasingly recommend two doses to provide stronger, longer-lasting protection against varicella. The trial will evaluate the immunogenicity and safety of two doses in